STOCK TITAN

Clinical Research Alliance Announces Clinical Trial Partnership with Vantage Health

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership clinical trial
Rhea-AI Summary

Optimus Healthcare Services (OTC Pink:OHCS) has announced a strategic partnership between Clinical Research Alliance (CRA) and Vantage Health to enhance cancer treatment and screening through new clinical trials in New York City. This collaboration aims to provide opportunities for underserved populations to participate in trials focused on breast and pancreatic cancer. CRA has conducted nearly 200 decentralized trials, emphasizing community access to innovative cancer treatments. Both organizations are committed to improving patient care and increasing early detection rates for cancer.

Positive
  • Strategic partnership with Vantage Health to enhance cancer treatment.
  • Focus on underserved populations for clinical trials.
  • CRA's experience with nearly 200 decentralized trials enhances credibility.
Negative
  • None.

Combining decades of expertise in delivering healthcare services and expanding patient access to clinical trials.

NEW YORK, NY / ACCESSWIRE / November 10, 2022 / Clinical Research Alliance (CRA), a division of Optimus Healthcare Services, Inc. (OTC Pink:OHCS), announced a new strategic partnership with Vantage Health, by which they will be offering clinical trials focused on improving cancer treatment modalities and increasing the quality of cancer screenings. Together, CRA and Vantage Health will be offering important clinical trials for cancer, including breast cancer and pancreatic cancer, for patients in the New York City area.

CRA is comprised of dedicated physicians and healthcare professionals that are committed to providing patients with the opportunity to participate in clinical trials testing potential cancer treatments in their local communities. CRA has a community-oriented mindset and is focused on helping underserved communities and patient populations. CRA assists local physicians in providing high quality patient care and integrity of clinical services on the front line of disease. CRA has participated in close to 200 decentralized trials delivering access to thousands of patients.

"We're proud of the work we've accomplished with leaders in the industry to serve patients locally in clinical trials, and we are looking forward to partnering with Vantage Health in order to improve healthcare for New York City area patients and beyond" said John Sganga, President and CEO of CRA.

Vantage Health has long been committed to compassionate, comprehensive cancer care and individualized attention for every patient. "At Vantage Health, we pride ourselves in going the extra mile for our patients. With these new trials, we will be able to offer patients who have tried other, more conventional therapies another potential treatment option. We will also be able to work towards improving current screening methods, increasing the probability of early detection. This is a win-win for patients" said Summer Sharaf CEO of Vantage Health.

Vantage Health positions community physicians to provide local, individualized, and compassionate care to patients at nine locations in New York City. With decades of combined experience in radiation oncology, surgery, urology, and hematology, Vantage Health's team includes award-winning physicians who are widely respected as innovative leaders in their fields.

About Clinical Research Alliance

CRA enables access to clinical research-making it easier for patients and providers to participate and accelerating the development of new and innovative cancer treatments that impact patient lives. By providing state-of-the-art clinical research in a community setting, they also make clinical research more accessible to underserved populations that enable faster enrollment, better retention and a patient population that is representative of real-world populations.

LinkedIn: clinical-research-alliance | Instagram: @clinicalresearchalliance | Facebook: @ClinicalResearchAlliance | https://www.clinicalresearchalliance.org/

About Vantage Health

Vantage Health positions community physicians to provide local, individualized, and compassionate care to patients at fourteen (14) locations in New York City. With decades of combined experience in radiation oncology, surgery, urology, and hematology, Vantage Health's team includes award-winning physicians who are widely respected as innovative leaders in their fields. https://www.vantagehealth.com/

Caution Concerning Forward Looking Statements:

This press release may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as "may," "will," "expect," "project," "estimate," "anticipate," "plan," "believe," "potential," "should," "continue" or the negative versions of those words or other comparable words. Forward-looking statements are not a guarantee of future actions or performance. These forward-looking statements are based on information currently available to Optimus and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning Optimus's business are described in Periodic and Current Reports filed with the OTCIQ and the SEC. Optimus is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Cliff Saffron, Chief Financial Officer
csaffron@theoptimushealthcare.com
516-806-4201

SOURCE: Optimus HealthCare Services, Inc.



View source version on accesswire.com:
https://www.accesswire.com/724635/Clinical-Research-Alliance-Announces-Clinical-Trial-Partnership-with-Vantage-Health

FAQ

What is the purpose of the partnership between Clinical Research Alliance and Vantage Health?

The partnership aims to improve cancer treatment modalities and increase the quality of cancer screenings through new clinical trials.

What types of cancer are involved in the new clinical trials announced by OHCS?

The trials will focus on breast cancer and pancreatic cancer.

How many decentralized trials has Clinical Research Alliance conducted?

Clinical Research Alliance has participated in nearly 200 decentralized trials.

What is the main benefit of the new clinical trials for patients?

Patients will gain access to potential new treatment options and improved screening methods that enhance early detection.

When was the partnership between CRA and Vantage Health announced?

The partnership was announced on November 10, 2022.

OPTIMUS HEALTHCARE SVCS

OTC:OHCS

OHCS Rankings

OHCS Latest News

OHCS Stock Data

5.21M
27.43M
48.73%
26.22%
Health Information Services
Healthcare
Link
United States of America
Westbury